Persistent URL of this record https://hdl.handle.net/1887/3715547
Documents
-
- Download
- PIIS0959804923000771
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma (vol 126, pg 93, 2020)
- All authors
- Decaudin, D.; Leitz, E.F.D.; Nemati, F.; Tarin, M.; Naguez, A.; Zerara, M.; Marande, B.; Vivet-Noguer, R.; Halilovic, E.; Fabre, C.; Jochemsen, A.; -Roman, S.R.; Alsafadi, S.
- Date
- 2023-04-11
- Journal
- European Journal of Cancer
- Volume
- 184
- Pages
- 199 - 199
- Link
- https://www.ejcancer.com/article/S0959-8049(23)00077-1/fulltext